Stocksigma LogoStocksigma Logo

Cohance Lifesciences Receives USFDA EIR with VAI Status for Pashamylaram Facility

Cohance Lifesciences Limited has received the Establishment Inspection Report (EIR) from the USFDA for its manufacturing facility located at Pashamylaram

Cohance Lifesciences Receives USFDA EIR with VAI Status for Pashamylaram Facility

Cohance Lifesciences Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 4:41 pm

Cohance Lifesciences Receives USFDA EIR with VAI Status for Pashamylaram Facility Cohance Lifesciences Limited has received the Establishment Inspection Report (EIR) from the USFDA for its manufacturing facility located at Pashamylaram, Hyderabad (FEI No. 1000623515). The USFDA has classified the inspection outcome as Voluntary Action Indicated (VAI), successfully concluding the inspection previously communicated on 5th Aug'26.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements